@article{79bfc62b3b134ea096050f3bc12f6bd1,
title = "Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network",
abstract = "There is a small risk of cross infection with Pseudomonas aeruginosa in bronchiectasis, but the benefit of specialised clinics, chest physiotherapy and pulmonary rehabilitation outweigh theoretical risks.",
author = "Chalmers, {James D.} and Ringshausen, {Felix C.} and Bridget Harris and Elborn, {J. Stuart} and Annette Posthumus and Haworth, {Charles S.} and Nicola Pilkington and Eva Polverino and Thomas Ruddy and Stefano Aliberti and Goeminne, {Pieter C.} and Craig Winstanley and {De Soyza}, Anthony",
note = "We acknowledge the EMBARC registry steering committee, the ERN-Lung bronchiectasis core network and ERN-Lung steering committee who approved this document. Bridget Harris, Nicola Pilkington, Annette Posthumus and Thomas Ruddy are representatives of the broader EMBARC/ELF bronchiectasis patient advisory group. EMBARC is a European Respiratory Society Clinical Research Collaboration. This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking iABC grant agreement n° 115721. JDC is supported by the GSK/British Lung Foundation Chair of Respiratory Research. ",
year = "2018",
month = jan,
day = "1",
doi = "10.1183/13993003.01937-2017",
language = "English",
volume = "51",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "1",
}